share_log
Breakings ·  Jun 26 21:01
Oramed Pharmaceuticals - Authorized Common Stock Repurchase Plan Allowing for Buy-Back of up to $20 Mln in Maximum Value of Its Common Stock
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment